NIVF:NASDAQNewGenIvf Group Limited Analysis

NewGenIvf is trading well below its short‑term moving averages, with price sitting under the 20‑day and 50‑day SMA, signaling a strong bearish technical stance. Momentum indicators such as the RSI are deep in oversold territory and the MACD remains bearish, while the stock faces a steep volatility profile and a beta more than twice the market, underscoring heightened price swings. Fundamentally, the company appears dramatically undervalued with ultra‑low PE and price‑to‑book multiples, yet it is burdened by negative cash flows, a massive debt load relative to equity, and a near‑total drawdown, raising serious concerns about sustainability. The recent appointment of a Web3 leader and a plan to raise up to $30 million via tokenized bonds could provide short‑term capital relief, but the underlying operational and financial distress remains the dominant risk factor.